Tesamorelin 5 mg is a synthetic peptide formulated as a growth hormone–releasing hormone (GHRH) analogue, developed to stimulate the body’s natural production of growth hormone through pituitary activation. Unlike direct growth hormone adRead More
Dosage Strength:
5 Mg
Drug Class:
Growth Hormone Releasing Hormone Analogue
Peptide Type:
Synthetic Peptide
Amino Acid Length:
44 Amino Acids
Tesamorelin 5 mg is a synthetic peptide formulated as a growth hormone–releasing hormone (GHRH) analogue, developed to stimulate the body’s natural production of growth hormone through pituitary activation. Unlike direct growth hormone administration, Tesamorelin works by enhancing endogenous hormone release, supporting more physiological regulation. This peptide is widely recognized in clinical and research environments for its role in metabolic support and body composition management. By encouraging natural growth hormone secretion, Tesamorelin may help support fat metabolism while maintaining lean muscle mass and overall metabolic balance.
Key Features
| Dosage Strength | 5 mg |
| Drug Class | Growth hormone releasing hormone analogue |
| Peptide Type | Synthetic peptide |
| Amino Acid Length | 44 amino acids |
| Molecular Weight | ~5135 Da |
| Product Category | Endocrine therapy |
| Mechanism | Stimulates growth hormone release |
| Target Gland | Pituitary |
| Primary Use | Reduction of visceral fat |
| Administration Route | Subcutaneous injection |
| Target System | Endocrine |
| Dosage Form | Lyophilized powder |
| Appearance | White powder |
| Solubility | Water soluble |
| Storage | Refrigerated |
| Shelf Life | 24 months |
| Packaging Type | Sterile vial |
| Manufacturer | Pharmaceutical |
| Country Of Origin | Canada |
| Dosage Strength | 5 mg |
| Drug Class | Growth hormone releasing hormone analogue |
| Peptide Type | Synthetic peptide |
| Amino Acid Length | 44 amino acids |
| Molecular Weight | ~5135 Da |
| Product Category | Endocrine therapy |
| Mechanism | Stimulates growth hormone release |
| Target Gland | Pituitary |
| Primary Use | Reduction of visceral fat |
| Administration Route | Subcutaneous injection |
| Target System | Endocrine |
| Dosage Form | Lyophilized powder |
| Appearance | White powder |
| Solubility | Water soluble |
| Storage | Refrigerated |
| Shelf Life | 24 months |
| Packaging Type | Sterile vial |
| Manufacturer | Pharmaceutical |
| Country Of Origin | Canada |
3316 E Richert AveFresno, CA 93726, USA
GET DIRECTION